Dermatology News

Protection from the sun, heat and air pollution is important to keeping children healthy while they spend more time outside this summer, the AAP said this week as it announced tips for preventing illnesses related to outdoor activities.

Patients with rosacea, alopecia areata, psoriasis or atopic dermatitis all face an elevated risk for cardiovascular disease, according to a study.

If there is anything to know about dry skin as summertime sets in, it is that “it can still happen,” according to Stephen R. Humphrey, MD, Society for Pediatric Dermatology external marketing committee chair.

The FDA has approved Litfulo, a once-daily oral treatment, for the treatment of severe alopecia in individuals aged 12 years and older, Pfizer announced in a press release.

A 3-year-old girl came running into her house, crying loudly with pain in her right hand. Her mother noticed several flat red marks, but no break in the skin, and she assumed they were insect bites or stings.

Patients with psoriatic arthritis and axial involvement experienced greater improvement when treated with upadacitinib 15 mg compared with placebo and adalimumab, according to data published in Arthritis Research & Therapy.

Amjevita, Cigna’s adalimumab biosimilar that made its U.S. marketplace debut in January, has so far failed to make an impact among patients compared with the reference drug, according to a physician survey.

HOUSTON — There has been a 77% increase in tattoo-related infections since 2000, a study found, although researchers say the number of infections is likely much higher.

Revivv, a novel topical serum, led to meaningful improvements in hair growth with no adverse events in patients with androgenetic alopecia, according to a study.

Patients with anxiety or depression are less likely to exhibit healthy self-management for their rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis, according to data presented at EULAR 2023 Congress.